Gary B. Kaplan - Publications

Affiliations: 
University of Rhode Island, Providence, RI, United States 
Area:
Neuroscience Biology, Pharmacology

35/103 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Babb JA, Zuberer A, Heinrichs S, Rumbika KK, Alfiler L, Lakis GA, Leite-Morris KA, Kaplan GB. Disturbances in fear extinction learning after mild traumatic brain injury in mice are accompanied by alterations in dendritic plasticity in the medial prefrontal cortex and basolateral nucleus of the amygdala. Brain Research Bulletin. 198: 15-26. PMID 37031792 DOI: 10.1016/j.brainresbull.2023.04.001  0.727
2017 Kaplan GB, Leite-Morris KA, Wang L, Rumbika KK, Heinrichs SC, Zeng X, Wu L, Arena DT, Teng YD. PATHOPHYSIOLOGICAL BASES OF COMORBIDITY: TBI AND PTSD. Journal of Neurotrauma. PMID 29017388 DOI: 10.1089/Neu.2016.4953  0.69
2017 Kobrin KL, Arena DT, Heinrichs SC, Nguyen OH, Kaplan GB. Dopamine D1 receptor agonist treatment attenuates extinction of morphine conditioned place preference while increasing dendritic complexity in the nucleus accumbens core. Behavioural Brain Research. PMID 28089852 DOI: 10.1016/J.Bbr.2017.01.011  0.499
2015 Kobrin KL, Moody O, Arena DT, Moore CF, Heinrichs SC, Kaplan GB. Acquisition of morphine conditioned place preference increases the dendritic complexity of nucleus accumbens core neurons. Addiction Biology. PMID 26096355 DOI: 10.1111/Adb.12273  0.468
2014 Leite-Morris KA, Kobrin KL, Guy MD, Young AJ, Heinrichs SC, Kaplan GB. Extinction of opiate reward reduces dendritic arborization and c-Fos expression in the nucleus accumbens core. Behavioural Brain Research. 263: 51-9. PMID 24406724 DOI: 10.1016/J.Bbr.2013.12.041  0.753
2013 Heinrichs SC, Leite-Morris KA, Rasmusson AM, Kaplan GB. Repeated valproate treatment facilitates fear extinction under specific stimulus conditions. Neuroscience Letters. 552: 108-13. PMID 23916657 DOI: 10.1016/J.Neulet.2013.07.035  0.72
2013 Heinrichs SC, Leite-Morris KA, Guy MD, Goldberg LR, Young AJ, Kaplan GB. Dendritic structural plasticity in the basolateral amygdala after fear conditioning and its extinction in mice. Behavioural Brain Research. 248: 80-4. PMID 23570859 DOI: 10.1016/J.Bbr.2013.03.048  0.725
2013 Nic Dhonnchadha BÁ, Lin A, Leite-Morris KA, Kaplan GB, Man HY, Kantak KM. Alterations in expression and phosphorylation of GluA1 receptors following cocaine-cue extinction learning. Behavioural Brain Research. 238: 119-23. PMID 23085477 DOI: 10.1016/J.Bbr.2012.10.012  0.718
2012 Nic Dhonnchadha BÁ, Lovascio BF, Shrestha N, Lin A, Leite-Morris KA, Man HY, Kaplan GB, Kantak KM. Changes in expression of c-Fos protein following cocaine-cue extinction learning. Behavioural Brain Research. 234: 100-6. PMID 22721675 DOI: 10.1016/J.Bbr.2012.06.010  0.711
2011 Kaplan GB, Leite-Morris KA, Fan W, Young AJ, Guy MD. Opiate sensitization induces FosB/ΔFosB expression in prefrontal cortical, striatal and amygdala brain regions. Plos One. 6: e23574. PMID 21886798 DOI: 10.1371/Journal.Pone.0023574  0.759
2011 Kaplan GB, Moore KA. The use of cognitive enhancers in animal models of fear extinction. Pharmacology, Biochemistry, and Behavior. 99: 217-28. PMID 21256147 DOI: 10.1016/J.Pbb.2011.01.009  0.377
2011 Kaplan GB, Heinrichs SC, Carey RJ. Treatment of addiction and anxiety using extinction approaches: neural mechanisms and their treatment implications. Pharmacology, Biochemistry, and Behavior. 97: 619-25. PMID 20723558 DOI: 10.1016/J.Pbb.2010.08.004  0.381
2010 Kaplan GB, Vasterling JJ, Vedak PC. Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: role in pathogenesis and treatment. Behavioural Pharmacology. 21: 427-37. PMID 20679891 DOI: 10.1097/Fbp.0B013E32833D8Bc9  0.325
2010 Heinrichs SC, Leite-Morris KA, Carey RJ, Kaplan GB. Baclofen enhances extinction of opiate conditioned place preference. Behavioural Brain Research. 207: 353-9. PMID 19840820 DOI: 10.1016/J.Bbr.2009.10.013  0.756
2009 Kaplan GB, Leite-Morris KA, Klufas MA, Fan W. Intra-VTA adenosine A1 receptor activation blocks morphine stimulation of motor behavior and cortical and limbic Fos immunoreactivity. European Journal of Pharmacology. 602: 268-76. PMID 19027733 DOI: 10.1016/J.Ejphar.2008.10.052  0.754
2004 Turalba AV, Leite-Morris KA, Kaplan GB. Antipsychotics regulate cyclic AMP-dependent protein kinase and phosphorylated cyclic AMP response element-binding protein in striatal and cortical brain regions in mice. Neuroscience Letters. 357: 53-7. PMID 15036612 DOI: 10.1016/J.Neulet.2003.11.059  0.715
2004 Leite-Morris KA, Fukudome EY, Shoeb MH, Kaplan GB. GABA(B) receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate-induced motor sensitization. The Journal of Pharmacology and Experimental Therapeutics. 308: 667-78. PMID 14610238 DOI: 10.1124/Jpet.103.058412  0.74
2003 Kaplan GB, Leite-Morris KA, Joshi M, Shoeb MH, Carey RJ. Baclofen inhibits opiate-induced conditioned place preference and associated induction of Fos in cortical and limbic regions. Brain Research. 987: 122-5. PMID 14499954 DOI: 10.1016/S0006-8993(03)03218-9  0.754
2002 Leite-Morris KA, Fukudome EY, Kaplan GB. Opiate-induced motor stimulation is regulated by gamma-aminobutyric acid type B receptors found in the ventral tegmental area in mice. Neuroscience Letters. 317: 119-22. PMID 11755254 DOI: 10.1016/S0304-3940(01)02457-0  0.725
2001 Kaplan GB, Turalba AV. Acute antipsychotic treatment increases cyclic AMP-dependent protein kinase levels in dopaminergic brain regions Clinical Pharmacology and Therapeutics. 69.  0.317
1999 Kaplan GB, Bharmal NH, Leite-Morris KA, Adams WR. Role of adenosine A1 and A2A receptors in the alcohol withdrawal syndrome. Alcohol (Fayetteville, N.Y.). 19: 157-62. PMID 10548160 DOI: 10.1016/S0741-8329(99)00033-6  0.724
1999 Kaplan GB, Leite-Morris KA, Keith DJ. Differential effects of treatment with typical and atypical antipsychotic drugs on adenylyl cyclase and G proteins. Neuroscience Letters. 273: 147-50. PMID 10515180 DOI: 10.1016/S0304-3940(99)00610-2  0.724
1999 Weisberg SP, Kaplan GB. Adenosine receptor antagonists inhibit the development of morphine sensitization in the C57BL/6 mouse Neuroscience Letters. 264: 89-92. PMID 10320021 DOI: 10.1016/S0304-3940(99)00188-3  0.428
1999 Kaplan GB, Weisberg SP. Adenosine receptor antagonists inhibit the expression of opiate-induced locomotor sensitization in mice Clinical Pharmacology and Therapeutics. 65: 155.  0.349
1998 Kaplan GB, Coyle TS. Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation European Journal of Pharmacology. 362: 1-8. PMID 9865523 DOI: 10.1016/S0014-2999(98)00724-9  0.437
1998 Leite-Morris KA, Kaplan GB, Smith JG, Sears MT. Regulation of G proteins and adenylyl cyclase in brain regions of caffeine-tolerant and -dependent mice. Brain Research. 804: 52-62. PMID 9729274 DOI: 10.1016/S0006-8993(98)00582-4  0.741
1998 Kaplan GB, Sethi RK, McClelland EG, Leite-Morris KA. Regulation of G protein-mediated adenylyl cyclase in striatum and cortex of opiate-dependent and opiate withdrawing mice. Brain Research. 788: 104-10. PMID 9554971 DOI: 10.1016/S0006-8993(97)01524-2  0.75
1997 Kaplan GB, Leite-Morris KA. Up-regulation of adenosine transporter-binding sites in striatum and hypothalamus of opiate tolerant mice. Brain Research. 763: 215-20. PMID 9296562 DOI: 10.1016/S0006-8993(97)00413-7  0.743
1996 Kaplan GB, Sears MT. Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs Psychopharmacology. 123: 64-70. PMID 8741956 DOI: 10.1007/Bf02246282  0.442
1994 Kaplan GB, Leite-Morris KA, Sears MT. Alterations of adenosine A1 receptors in morphine dependence. Brain Research. 657: 347-50. PMID 7820640 DOI: 10.1016/0006-8993(94)90990-3  0.727
1993 Kaplan GB, Greenblatt DJ, Kent MA, Cotreau-Bibbo MM. Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding. The Journal of Pharmacology and Experimental Therapeutics. 266: 1563-72. PMID 8371158  0.309
1992 Kaplan GB, Greenblatt DJ, Kent MA, Cotreau MM, Arcelin G, Shader RI. Caffeine-induced behavioral stimulation is dose-dependent and associated with A1 adenosine receptor occupancy. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 6: 145-53. PMID 1599605  0.301
1992 KAPLAN GB, COTREAU MM, GREENBLATT DJ. Effects of benzodiazepine administration on A1 adenosine receptor binding in‐vivo and ex‐vivo Journal of Pharmacy and Pharmacology. 44: 700-703. PMID 1359103 DOI: 10.1111/J.2042-7158.1992.Tb05502.X  0.381
1990 Kaplan GB, Tai NT, Greenblatt DJ, Shader RI. Separate and combined effects of caffeine and alprazolam on motor activity and benzodiazepine receptor binding in vivo Psychopharmacology. 101: 539-544. PMID 2167493 DOI: 10.1007/Bf02244234  0.4
1989 Lopez F, Miller LG, Greenblatt DJ, Kaplan GB, Shader RI. Interaction of caffeine with the GABAA receptor complex: alterations in receptor function but not ligand binding European Journal of Pharmacology: Molecular Pharmacology. 172: 453-459. PMID 2482188 DOI: 10.1016/0922-4106(89)90028-X  0.371
Low-probability matches (unlikely to be authored by this person)
2023 Kaplan GB, Thompson BL. Neuroplasticity of the extended amygdala in opioid withdrawal and prolonged opioid abstinence. Frontiers in Pharmacology. 14: 1253736. PMID 38044942 DOI: 10.3389/fphar.2023.1253736  0.297
2004 Kaplan GB, McRoberts RL, Smokler HJ. Baclofen as adjunctive treatment for a patient with cocaine dependence and schizoaffective disorder. Journal of Clinical Psychopharmacology. 24: 574-5. PMID 15349029 DOI: 10.1097/01.Jcp.0000138778.78633.45  0.291
1990 Kaplan GB, Tai NT, Greenblatt DJ, Shader RI. Caffeine-induced behavioural stimulation is dose- and concentration-dependent British Journal of Pharmacology. 100: 435-440. PMID 2390669 DOI: 10.1111/J.1476-5381.1990.Tb15824.X  0.291
2007 Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, MacKinnon SV, Sirota AD, Kaplan GB. High-dose transdermal nicotine and naltrexone: effects on nicotine withdrawal, urges, smoking, and effects of smoking. Experimental and Clinical Psychopharmacology. 15: 81-92. PMID 17295587 DOI: 10.1037/1064-1297.15.1.81  0.29
2000 Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Harmatz JS, Shader RI. Differences in pharmacodynamics but not pharmacokinetics between subjects with panic disorder and healthy subjects after treatment with a single dose of alprazolam. Journal of Clinical Psychopharmacology. 20: 338-46. PMID 10831021 DOI: 10.1097/00004714-200006000-00008  0.282
2012 Ahnallen CG, Liverant GI, Gregor KL, Kamholz BW, Levitt JJ, Gulliver SB, Pizzagalli DA, Koneru VK, Kaplan GB. The relationship between reward-based learning and nicotine dependence in smokers with schizophrenia. Psychiatry Research. 196: 9-14. PMID 22342123 DOI: 10.1016/J.Psychres.2011.09.011  0.276
1997 Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Cotreau MM, Harmatz JS, Shader RI. Dose-dependent pharmacokinetics and psychomotor effects of caffeine in humans. Journal of Clinical Pharmacology. 37: 693-703. PMID 9378841 DOI: 10.1002/J.1552-4604.1997.Tb04356.X  0.273
2020 Thompson BL, Oscar-Berman M, Kaplan GB. Opioid-induced Structural and Functional Plasticity of Medium-Spiny Neurons in the Nucleus Accumbens. Neuroscience and Biobehavioral Reviews. PMID 33152423 DOI: 10.1016/j.neubiorev.2020.10.015  0.269
1998 Kaplan GB, Greenblatt DJ, Ehrenberg BL, Goddard JE, Harmatz JS, Shader RI. Single-dose pharmacokinetics and pharmacodynamics of alprazolam in elderly and young subjects. Journal of Clinical Pharmacology. 38: 14-21. PMID 9597554 DOI: 10.1002/J.1552-4604.1998.Tb04370.X  0.267
2000 Rohsenow DJ, Monti PM, Hutchison KE, Swift RM, Colby SM, Kaplan GB. Naltrexone's effects on reactivity to alcohol cues among alcoholic men. Journal of Abnormal Psychology. 109: 738-42. PMID 11195999 DOI: 10.1037/0021-843X.109.4.738  0.265
2008 Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Adolfo AB. Effects of smoking abstinence, smoking cues and nicotine replacement in smokers with schizophrenia and controls. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 10: 1047-56. PMID 18584468 DOI: 10.1080/14622200802097373  0.262
2011 Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Reid N. Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology. 217: 279-87. PMID 21475970 DOI: 10.1007/S00213-011-2282-8  0.256
2014 Liverant GI, Sloan DM, Pizzagalli DA, Harte CB, Kamholz BW, Rosebrock LE, Cohen AL, Fava M, Kaplan GB. Associations among smoking, anhedonia, and reward learning in depression. Behavior Therapy. 45: 651-63. PMID 25022776 DOI: 10.1016/J.Beth.2014.02.004  0.255
2005 Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM. Subjective and physiological responses to smoking cues in smokers with schizophrenia. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 7: 421-9. PMID 16085510 DOI: 10.1080/14622200500125724  0.243
2013 Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM, Ahnallen CG. Separate and combined effects of very low nicotine cigarettes and nicotine replacement in smokers with schizophrenia and controls. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 15: 121-9. PMID 22517190 DOI: 10.1093/Ntr/Nts098  0.233
2010 Sirota AD, Rohsenow DJ, Mackinnon SV, Martin RA, Eaton CA, Kaplan GB, Monti PM, Tidey JW, Swift RM. Intolerance for Smoking Abstinence Questionnaire: psychometric properties and relationship to tobacco dependence and abstinence. Addictive Behaviors. 35: 686-93. PMID 20381260 DOI: 10.1016/J.Addbeh.2010.02.014  0.222
2005 Tidey JW, Rohsenow DJ, Kaplan GB, Swift RM. Cigarette smoking topography in smokers with schizophrenia and matched non-psychiatric controls. Drug and Alcohol Dependence. 80: 259-65. PMID 15869844 DOI: 10.1016/J.Drugalcdep.2005.04.002  0.218
2022 Kaplan GB, Lakis GA, Zhoba H. Sleep-Wake and Arousal Dysfunctions in Post-Traumatic Stress Disorder:Role of Orexin Systems. Brain Research Bulletin. PMID 35618150 DOI: 10.1016/j.brainresbull.2022.05.006  0.217
2023 Babb JA, Constantino NJ, Kaplan GB, Chartoff EH. Estrous cycle dependent expression of oxycodone conditioned reward in rats. Scientific Reports. 13: 13946. PMID 37626154 DOI: 10.1038/s41598-023-40971-3  0.212
1989 Kaplan GB, Greenblatt DJ, Leduc BW, Thompson ML, Shader RI. Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity Journal of Pharmacology and Experimental Therapeutics. 248: 1078-1083. PMID 2539455  0.21
2013 Harte CB, Liverant GI, Sloan DM, Kamholz BW, Rosebrock LE, Fava M, Kaplan GB. Association between smoking and heart rate variability among individuals with depression. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 46: 73-80. PMID 23436273 DOI: 10.1007/S12160-013-9476-8  0.197
2006 Epstein-Lubow G, Hochstadt J, Lieberman P, Kaplan GB. Speech production in schizophrenia: preliminary data regarding voice onset time. Schizophrenia Research. 82: 267-9. PMID 16371248 DOI: 10.1016/J.Schres.2005.11.005  0.181
2006 Kaplan GB, Phillips KA, Vaccaro A, Eisen JL, Posternak MA, MacAskill HS. Assessment of insight into delusional beliefs in schizophrenia using the Brown Assessment of Beliefs Scale. Schizophrenia Research. 82: 279-81. PMID 16406495 DOI: 10.1016/J.Schres.2005.11.009  0.176
1992 Kaplan GB. Neurobiological aspects of panic disorder Rhode Island Medicine. 75: 247-251. PMID 1351409  0.173
1989 Kaplan GB. Human Psychopharmacology Journal of Clinical Psychopharmacology. 9: 456. DOI: 10.1097/00004714-198912000-00029  0.173
2023 Kaplan GB, Dadhi NA, Whitaker CS. Mitochondrial dysfunction in animal models of PTSD: Relationships between behavioral models, neural regions, and cellular maladaptation. Frontiers in Physiology. 14: 1105839. PMID 36923289 DOI: 10.3389/fphys.2023.1105839  0.169
2023 Patterson BK, Yogendra R, Guevara-Coto J, Mora-Rodriguez RA, Osgood E, Bream J, Parikh P, Kreimer M, Jeffers D, Rutland C, Kaplan G, Zgoda M. Case series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequelae of COVID (PASC). Frontiers in Medicine. 10: 1122529. PMID 36844201 DOI: 10.3389/fmed.2023.1122529  0.156
1996 Kaplan G, Leite-Morris K, Sears M, McClelland E, Sethi R. Regulation of adenosine- and G protein-mediated signalling in opiate dependence Biological Psychiatry. 39: 505. DOI: 10.1016/0006-3223(96)83969-2  0.153
2021 Liverant GI, Gallagher MW, Arditte Hall KA, Rosebrock LE, Black SK, Kind S, Fava M, Kaplan GB, Kamholz BW, Pineles SL, Sloan DM. Suppression and acceptance in unipolar depression: Short-term and long-term effects on emotional responding. The British Journal of Clinical Psychology. PMID 34268773 DOI: 10.1111/bjc.12323  0.108
2001 Kaplan GB, Genç I, Güzeliş C. A simple neural network system for wisconsin card sorting test Annual Reports of the Research Reactor Institute, Kyoto University. 1: 700-703.  0.107
2019 Shimasaki C, Frye RE, Trifiletti R, Cooperstock M, Kaplan G, Melamed I, Greenberg R, Katz A, Fier E, Kem D, Traver D, Dempsey T, Latimer ME, Cross A, Dunn JP, et al. Evaluation of the Cunningham Panel™ in pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection (PANDAS) and pediatric acute-onset neuropsychiatric syndrome (PANS): Changes in antineuronal antibody titers parallel changes in patient symptoms. Journal of Neuroimmunology. 339: 577138. PMID 31884258 DOI: 10.1016/j.jneuroim.2019.577138  0.105
2007 Kaplan GB, Şengör NS, Gürvit H, Güzeliş C. Modelling the Stroop effect: A connectionist approach Neurocomputing. 70: 1414-1423. DOI: 10.1016/j.neucom.2006.05.009  0.094
2022 Brown RE, Spratt TJ, Kaplan GB. Translational approaches to influence sleep and arousal. Brain Research Bulletin. 185: 140-161. PMID 35550156 DOI: 10.1016/j.brainresbull.2022.05.002  0.085
2012 Vasu TS, Cavallazzi R, Hirani A, Kaplan G, Leiby B, Marik PE. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials. Journal of Intensive Care Medicine. 27: 172-8. PMID 21436167 DOI: 10.1177/0885066610396312  0.084
2006 Kaplan GB, Şengör NS, Gürvit H, Genç I, Güzeliş C. A composite neural network model for perseveration and distractibility in the Wisconsin card sorting test Neural Networks. 19: 375-387. PMID 16343846 DOI: 10.1016/j.neunet.2005.08.015  0.08
1985 Arana GW, Kaplan GB. Trazodone-induced mania following desipramine-induced mania in major depressive disorders American Journal of Psychiatry. 142: 386. PMID 3970283  0.072
1996 Corral LG, Muller GW, Moreira AL, Chen Y, Wu M, Stirling D, Kaplan G. Selection of Novel Analogs of Thalidomide with Enhanced Tumor Necrosis Factor α Inhibitory Activity Molecular Medicine. 2: 506-515. DOI: 10.1007/BF03401909  0.066
2021 Balser J, Ryu J, Hood M, Kaplan G, Perlin J, Siegel B. Care Systems COVID-19 Impact Assessment: Lessons Learned and Compelling Needs. Nam Perspectives. 2021. PMID 34532691 DOI: 10.31478/202104d  0.055
2021 Grampurohit N, Bell A, Duff S, Mulcahey MJ, Thielen CC, Kaplan G, Marino RJ. Highlighting gaps in spinal cord injury research in activity-based interventions for the upper extremity: A scoping review. Neurorehabilitation. PMID 33967071 DOI: 10.3233/NRE-210042  0.052
2004 Bahadirlar Y, Kaplan GB. Frequency-domain preprocessing and directional correlation-based feature extraction for classification of the buried objects using GPR B-scan data Proceedings of Spie - the International Society For Optical Engineering. 5415: 905-912. DOI: 10.1117/12.541995  0.052
2012 Smith M, Halvorson G, Kaplan G. What's needed is a health care system that learns: recommendations from an IOM report. Jama. 308: 1637-8. PMID 23093161 DOI: 10.1001/jama.2012.13664  0.044
1999 Kaplan GB, Güzeliş C. Hopfield networks for solving tower of Hanoi problem Computers and Computational Engineering in Control. 114-119.  0.044
2003 Petrikovsky BM, Kaplan G, Holsten N. Eyelid movements in normal human fetuses. Journal of Clinical Ultrasound : Jcu. 31: 299-301. PMID 12811788 DOI: 10.1002/jcu.10173  0.04
1977 Kaplan GB, Pameijer CH, Ruben MP. Scanning electron microscopy of sulcular and junctional epithelia correlated with histology (part I) Journal of Periodontology. 48: 446-451. PMID 409830  0.04
2011 Kaplan GB, Yoldemir AB, Içoǧlu O, Sezgin M. Discrimination of buried objects using angular radial transform and multi-layer perceptrons International Radar Symposium, Irs 2011 - Proceedings. 116-121.  0.039
2005 Kaplan GB. PROSSA challenge Sadj : Journal of the South African Dental Association = Tydskrif Van Die Suid-Afrikaanse Tandheelkundige Vereniging. 60: 2. PMID 15861953  0.037
2010 Kaplan GB, Içoǧlu O, Yoldemir AB, Sezgin M. Real-time object detection using dynamic principal component analysis Proceedings of the 13th Internarional Conference On Ground Penetrating Radar, Gpr 2010. DOI: 10.1109/ICGPR.2010.5550088  0.036
1968 Moody JE, Hohmann JR, Kaplan GB. Chemical determination of the potency of thyroid preparations Journal of Pharmaceutical Sciences. 57: 634-639. PMID 5652155 DOI: 10.1002/jps.2600570419  0.036
2011 Yoldemir AB, Gürcan R, Kaplan GB, Sezgin M. Comparative analysis of clutter suppression techniques for landmine detection using ground penetrating radar Proceedings of Spie - the International Society For Optical Engineering. 8017. DOI: 10.1117/12.895415  0.035
1972 Kaplan GB, Levine J. Column chromatographic assay for sodium butabarbital in tablets Journal of the Association of Official Analytical Chemists. 55: 152-154. PMID 4666835  0.033
2019 Grampurohit N, Marino R, Bell A, Duff S, Kaplan G, Thielen C, Mulcahey M. A Scoping Review of Activity-based Therapy for the Neurologically Impaired Upper Extremity Archives of Physical Medicine and Rehabilitation. 100: e213. DOI: 10.1016/J.Apmr.2019.10.161  0.031
2018 Thielen CC, Marino RJ, Duff S, Kaplan G, Mulcahey MJ. Activity-based Rehabilitation Interventions of the Neurologically Impaired Upper Extremity: Description of a Scoping Review Protocol. Topics in Spinal Cord Injury Rehabilitation. 24: 288-294. PMID 29997431 DOI: 10.1310/Sci2403-288  0.03
1974 Kaplan GB, Levine J. Determination of prednisolone sodium phosphate by ion-pair extraction Journal of the Association of Official Analytical Chemists. 57: 735-737. PMID 4833418  0.024
2013 Kaplan GB, Lana A. Comparison of proposed target tracking algorithm, GRNNa, to Kalman Filter in 3D environment Proceedings International Radar Symposium. 1: 387-392.  0.024
2021 Hermanson S, Pujari A, Williams B, Blackmore C, Kaplan G. Successes and challenges of implementing an integrative medicine practice in an allopathic medical center. Healthcare (Amsterdam, Netherlands). 9: 100457. PMID 33607518 DOI: 10.1016/j.hjdsi.2020.100457  0.023
2006 Kaplan GB. Teaching to the masses: The design and implementation of a large lecture hispanic culture course Foreign Language Annals. 39: 413-434. DOI: 10.1111/j.1944-9720.2006.tb02897.x  0.021
2013 Lana A, Kaplan GB. Enhanced cluster seeking algorithm for tracking flocks of birds Proceedings International Radar Symposium. 2: 573-577.  0.02
2013 Selberg J, Pronovost P, Kaplan G. Culture conscious. Leaders talk quality, change needed for improvement at Virtual Conference. Modern Healthcare. 43: 18, 22. PMID 23875235  0.017
2014 Kaplan G, Robeznieks A. Prospering by standardizing processes and improving the patient experience. Modern Healthcare. 44: 28-9. PMID 24693751  0.013
2022 Brown RE, Kaplan GB. Introduction to special issue: Sleep and arousal in health and disease. Brain Research Bulletin. 188: 131-132. PMID 35918033 DOI: 10.1016/j.brainresbull.2022.07.021  0.01
2012 Gabow P, Halvorson G, Kaplan G. Marshaling leadership for high-value health care: an Institute of Medicine discussion paper. Jama. 308: 239-40. PMID 22669121 DOI: 10.1001/jama.2012.7081  0.01
2012 Kaplan GB. The inception of limpieza de sangre (purity of blood) and its impact in medieval and golden age Spain Medieval and Early Modern Iberian World. 46: 19-41.  0.01
2012 Aronson-Friedman AI, Kaplan GB. Editors' introduction to marginal voices: Studies in converso literature of medieval and golden age Spain Medieval and Early Modern Iberian World. 46: 1-17.  0.01
2006 Brown L, Buckley J, Gibbs D, Kaplan G, Lofton K, McDonagh K, Schrader A, Vaughn A, Whetsell G, Wade R. Executive dialogue series. Performance improvement in the era of quality improvement. Hospitals & Health Networks / Aha. 80: 80-9. PMID 17216797  0.01
2006 Brown L, Buckley J, Gibbs D, Kaplan G, Lofton K, McDonagh K, Schrader A, Vaughn A, Whetsell G, Wade R. Performance improvement in the era of quality improvement. Trustee : the Journal For Hospital Governing Boards. 59: 41-51, 1. PMID 17058707  0.01
2006 Kaplan G. Interview with Gary Kaplan [interview by J L Reinertsen] . Quality & Safety in Health Care. 15: 156-8. PMID 16751462 DOI: 10.1136/qshc.2006.018283  0.01
2002 Kaplan GB. The (Columbian) myth of Syphilis: A textual perspective Hispanofila. 21-35.  0.01
1977 Kaplan GB, Ruben MP, Pameijer CH. Scanning electron microscopy of the epithelium of the periodontal pocket - Part II Journal of Periodontology. 48: 634-638. PMID 409829  0.01
Hide low-probability matches.